Cargando…

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination

BACKGROUND: Antibody levels decrease substantially at 6 months after the BNT162b2 vaccine. The factors influencing titer of antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare workers for coronavirus disease 2019 (COVID-19) is unclear. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurashima, Kazuyoshi, Numano, Tsuyoshi, Yoshino, Atsuki, Osawa, Akiko, Takaku, Yotaro, Kagiyama, Naho, Yanagisawa, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393162/ https://www.ncbi.nlm.nih.gov/pubmed/36030124 http://dx.doi.org/10.1016/j.vaccine.2022.08.035

Ejemplares similares

Diffuse alveolar hemorrhage caused by IgA deposition associated with multiple myeloma
por: Furube, Atsuki, et al.
Publicado: (2019)

Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
por: Ishiguro, Takashi, et al.
Publicado: (2016)

Restrictive ventilatory impairment improved by laminoplasty for ossification of the posterior longitudinal ligament
por: Nishida, Takashi, et al.
Publicado: (2018)

Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality
por: Ishiguro, Takashi, et al.
Publicado: (2017)

Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole
por: Ishiguro, Takashi, et al.
Publicado: (2018)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer
por: Isono, Taisuke, et al.
Publicado: (2021)

Smoking history and emphysema in asthma–COPD overlap
por: Kurashima, Kazuyoshi, et al.
Publicado: (2017)

Changes in airway diameter and mucus plugs in patients with asthma exacerbation
por: Yoshida, Yuki, et al.
Publicado: (2020)

Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Isono, Taisuke, et al.
Publicado: (2020)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
por: Zapata-Cardona, María I., et al.
Publicado: (2022)

Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD
por: Kurashima, Kazuyoshi, et al.
Publicado: (2015)

Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia
por: Ishiguro, Takashi, et al.
Publicado: (2020)

Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis
por: Wakabayashi, Aya, et al.
Publicado: (2018)

Allergic Bronchopulmonary Mycosis Caused by Schizophyllum commune: A Special Interest in Positive Culture of Other Basidiomycetes Fungi
por: Ito, Akihiko, et al.
Publicado: (2019)

Clinical Features of Fibrosing Mediastinitis in Japanese Patients: Two Case Reports and a Literature Review
por: Kobayashi, Yoichi, et al.
Publicado: (2021)

Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine
por: Uwamino, Yoshifumi, et al.
Publicado: (2022)

Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
por: Jo, Dong-Ho, et al.
Publicado: (2021)

Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine
por: Ferrari, Davide, et al.
Publicado: (2021)

Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
por: Kato, Eisuke, et al.
Publicado: (2018)

Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
por: Izumo, Takehiro, et al.
Publicado: (2021)

Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months
por: Nomura, Yushi, et al.
Publicado: (2021)

Blood Antibody Titers and Adverse Reactions after BNT162b2 mRNA Vaccination
por: Kiewisz, Jolanta, et al.
Publicado: (2022)

Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients
por: Takazono, Takahiro, et al.
Publicado: (2023)

Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination
por: Koike, Ryousuke, et al.
Publicado: (2022)

Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
por: Mochizuki, Takeshi, et al.
Publicado: (2023)

Viral Pneumonia Requiring Differentiation from Acute and Progressive Diffuse Interstitial Lung Diseases
por: Ishiguro, Takashi, et al.
Publicado: (2019)

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
por: Coggins, Si’Ana A, et al.
Publicado: (2021)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
por: Levy, Itzchak, et al.
Publicado: (2022)

Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers
por: Yamamoto, Shohei, et al.
Publicado: (2022)

Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients
por: El Haggan, Wael, et al.
Publicado: (2022)

Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis
por: Kagiyama, Naho, et al.
Publicado: (2015)

Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
por: Morales-Núñez, José Javier, et al.
Publicado: (2021)

Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers
por: Campo, Flaminia, et al.
Publicado: (2021)

Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine
por: Ferrari, Davide, et al.
Publicado: (2022)

Sex‐associated differences between BMI and SARS‐CoV‐2 antibody titers following the BNT162b2 vaccine
por: Yamamoto, Shohei, et al.
Publicado: (2022)

One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine
por: Wand, Ori, et al.
Publicado: (2023)

Antibody titres decline 3-month post-vaccination with BNT162b2
por: Favresse, Julien, et al.
Publicado: (2021)

Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
por: Coppeta, Luca, et al.
Publicado: (2022)

Changes in SARS-CoV-2 Antibody Titers from Three to Nine Months after Administration of the BNT162b2 mRNA Vaccine among Healthcare Workers in Japan: A Prospective Study
por: Mochizuki, Takeshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dm7ov0qoj5amkvo4ore79a74g3